Literature DB >> 10985586

Reversed-phase high-performance liquid chromatography of catecholamines and indoleamines using a simple gradient solvent system and native fluorescence detection.

A T Wood1, M R Hall.   

Abstract

A reversed-phase HPLC method using a C18 column and a two-mobile-phase gradient elution system containing only volatile components has been developed for separation of norepinephrine, octopamine, epinephrine, dopamine, dihydroxyphenylalanine, tyramine, tyrosine, serotonin, 5-hydroxytryptophan, N-acetyl-serotonin and tryptophan. Mobile phase A contains 0.05% aqueous trifluoroacetic acid and methanol (97.5:2.5, v/v) and mobile phase B contains 0.05% aqueous trifluoracetic acid and methanol (40:60, v/v). This method has the advantage that the mobile phase can be removed completely, without salt residues, from the eluted fractions thus simplifying further analytical procedures on isolated fractions. The elution profile of standards is related to structural characteristics allowing prediction of retention times of known compounds and insight into possible structural characteristics of unknown components in a mixture. Detection is via native fluorescence using excitation at 220 nm and emission at 320 nm and under the conditions described has a sensitivity range from 2.5 to 25 pmol, although the sensitivity range can be extended depending on the emission wavelength used.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10985586     DOI: 10.1016/s0378-4347(00)00249-8

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Sci Appl        ISSN: 1387-2273


  2 in total

1.  Toward the understanding of the metabolism of levodopa I. DFT investigation of the equilibrium geometries, acid-base properties and levodopa-water complexes.

Authors:  Shabaan A K Elroby; Mohamed S I Makki; Tariq R Sobahi; Rifaat H Hilal
Journal:  Int J Mol Sci       Date:  2012-04-02       Impact factor: 6.208

2.  Single- and multi-component chiral supraparticles as modular enantioselective catalysts.

Authors:  Si Li; Juan Liu; Naomi S Ramesar; Hendrik Heinz; Liguang Xu; Chuanlai Xu; Nicholas A Kotov
Journal:  Nat Commun       Date:  2019-10-23       Impact factor: 14.919

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.